Cargando…

Characterization of a canine model of glycogen storage disease type IIIa

Glycogen storage disease type IIIa (GSD IIIa) is an autosomal recessive disease caused by deficiency of glycogen debranching enzyme (GDE) in liver and muscle. The disorder is clinically heterogeneous and progressive, and there is no effective treatment. Previously, a naturally occurring dog model fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Haiqing, Thurberg, Beth L., Curtis, Sarah, Austin, Stephanie, Fyfe, John, Koeberl, Dwight D., Kishnani, Priya S., Sun, Baodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484863/ https://www.ncbi.nlm.nih.gov/pubmed/22736456 http://dx.doi.org/10.1242/dmm.009712

Ejemplares similares

Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV
por: Yi, Haiqing, et al.
Publicado: (2016)

Diurnal variability of glucose tetrasaccharide (Glc(4)) excretion in patients with glycogen storage disease type III
por: Young, Sarah P., et al.
Publicado: (2020)

Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice
por: Lim, Jeong-A, et al.
Publicado: (2022)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

Glycogen storage disease type IIIa in pregnant women: A guide to management
por: Beneru, Demi, et al.
Publicado: (2022)

Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease
por: Kang, Hye-Ri, et al.
Publicado: (2019)

"Bull’s eye” appearance of hepatocellular adenomas in patients with glycogen storage disease type I — atypical magnetic resonance imaging findings: Two case reports
por: Vernuccio, Federica, et al.
Publicado: (2021)

Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?
por: El-Gharbawy, Areeg, et al.
Publicado: (2022)

Genetic analysis and clinical assessment of four patients with Glycogen Storage Disease Type IIIa in China
por: Zhang, Yu, et al.
Publicado: (2018)

Liver Transplantation in a Myopathic Patient with Glycogen Storage Disease Type IIIa and Decompensated Cirrhosis
por: Zobeiri, M.
Publicado: (2017)

Data highlighting effects of Ketogenic diet on cardiomyopathy and hepatopathy in Glycogen storage disease Type IIIA
por: Marusic, Tatiana, et al.
Publicado: (2020)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III
por: Hijazi, Ghada, et al.
Publicado: (2021)

Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study
por: Hennis, Philip J., et al.
Publicado: (2022)

A Novel Nonsense Mutation of the AGL Gene in a Romanian Patient with Glycogen Storage Disease Type IIIa
por: Zimmermann, Anca, et al.
Publicado: (2016)

Normalization of obstructive cardiomyopathy and improvement of hepatopathy on ketogenic diet in patient with glycogen storage disease (GSD) type IIIa
por: Marusic, Tatiana, et al.
Publicado: (2020)

Anesthetic management for dental surgery in a child with glycogen storage disease type IIIa: a case report
por: Aykenar, Buğra, et al.
Publicado: (2022)

A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme
por: Lim, Jeong-A, et al.
Publicado: (2020)

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
por: Jackson, David G., et al.
Publicado: (2023)

The Novel Compound Heterozygous Mutations in the AGL Gene in a Chinese Family With Adult Late-Onset Glycogen Storage Disease Type IIIa
por: Qu, Qianqian, et al.
Publicado: (2020)

Hydrostatic Isolated Limb Perfusion with Adeno-associated Virus Vectors Enhances Correction of Skeletal Muscle in Pompe Disease
por: Sun, Baodong, et al.
Publicado: (2010)

Effects of acute nutritional ketosis during exercise in adults with glycogen storage disease type IIIa are phenotype‐specific: An investigator‐initiated, randomized, crossover study
por: Hoogeveen, Irene J., et al.
Publicado: (2020)

Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease
por: Specht, Andrew, et al.
Publicado: (2011)

Screening data from 19 patients with late‐onset Pompe disease for a phase I clinical trial of AAV8 vector‐mediated gene therapy
por: Hannah, William B., et al.
Publicado: (2023)

Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase Rescues Both Muscle and CNS Defects in Murine Pompe Disease
por: Lim, Jeong-A, et al.
Publicado: (2019)

From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia
por: Chandler, Randy J.
Publicado: (2023)

The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI
por: Grünert, Sarah Catharina, et al.
Publicado: (2021)

A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease
por: Lim, Han-Hyuk, et al.
Publicado: (2017)

Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations
por: Rossi, Alessandro, et al.
Publicado: (2020)

Improvement in hypertrophic cardiomyopathy after using a high-fat, high-protein and low-carbohydrate diet in a non-adherent child with glycogen storage disease type IIIa
por: Kumru Akin, Burcu, et al.
Publicado: (2022)

Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report
por: Thurberg, Beth L.
Publicado: (2020)

Liver transplantation in glycogen storage disease type I
por: Boers, Susanna JB, et al.
Publicado: (2014)

Pulmonary Hypertension in Glycogen Storage Disease Type II
por: Li, Hui-Ping, et al.
Publicado: (2018)

Liver Transplantation for Glycogen Storage Disease Type IV
por: Liu, Min, et al.
Publicado: (2021)

Successful pregnancy in a woman with glycogen storage disease type 6
por: Grünert, Sarah Catharina, et al.
Publicado: (2021)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly
por: Kim, Jung Ah, et al.
Publicado: (2015)

Long term outcome and clinical experience on immune tolerance induction therapies in infantile Pompe disease
por: Austin, Stephanie, et al.
Publicado: (2013)

Glycogen storage disease type IV: a case report.
por: Lee, K. Y., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_1brqim2rctn7atn41gad0srnmo